Skip to content
AnalystLens

WELLS FARGO & COMPANY/MN 8-K Report, Corporate Update (Apr 30, 2025)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed April 30, 2025
Period End
April 23, 2025
In the record · 2016–202610-K410-Q128-K584

WFC filed 4 annual reports (10-K), 12 quarterly reports (10-Q) and 584 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Apr ’17Apr ’17
  2. Leadership change8-K · Apr ’19Apr ’19

Summary

Summary of the 8-K filed April 30, 2025. Cited figures are marked; the original filing is the authoritative source.

Wells Fargo & Company disclosed in this April 30, 2025 Form 8-K (Item 8.01) the proposed settlement of a California state shareholder derivative action, Himstreet et al. v.

Scharf et al. (Case No. CGC-22-599223), following preliminary approval by the San Francisco Superior Court on April 23, 2025. The suit alleged that the individual defendants, including current and former senior leaders and directors, breached fiduciary duties by mismanaging and failing to comply with a series of regulatory consent orders covering consumer banking practices and risk management.

The company is furnishing the court-mandated notice (Exhibit 99.1) and the stipulated settlement agreement (Exhibit 99.2) to inform shareholders. The core economic term is a $100 milliona monetary payment, funded by the company's directors' and officers' (D&O) excess insurers and paid to Wells Fargo, not to shareholders directly, within 15 calendar days of the Effective Date. Wells Fargo has also implemented corporate governance reforms during the litigation, including enhanced risk management oversight, additional employee training, and changes to Board composition.

The defendants deny all wrongdoing and entered the settlement to avoid the cost and uncertainty of continued litigation. Under the agreement, Wells Fargo will pay plaintiffs' counsel $33,333,333b in attorneys' fees and expenses, paid in Wells Fargo common stock, with a company top-up in cash or stock if the stock value falls below $33 million at payment. For investors, the filing is primarily a legal and governance disclosure with limited direct financial impact: the $100 million recovery is funded by insurance rather than company capital, and the derivative settlement is non-monetary for shareholders beyond the indirect benefit of the payment and reforms.

The settlement remains subject to a July 24, 2025 hearing before Judge Jeffrey S. Ross, and it is not yet final.

The filing also indicates that a related federal derivative action in the Northern District of California has been stayed pending resolution of this case, so the settlement could resolve that matter as well. Investors should note that the settlement's approval, the fee arrangement, and the release of claims tied to seven consent orders remain subject to court approval.

Key Highlights

  1. Settlement of a shareholder derivative action in San Francisco Superior Court alleging breach of fiduciary duty tied to noncompliance with regulatory consent orders on consumer banking and risk management.
  2. $100 million monetary consideration to Wells Fargo, funded by D&O excess insurers on behalf of the individual defendants, payable within 15 calendar days of the Effective Date.
  3. Shareholders receive no direct payment; they benefit indirectly through the $100 million recovery and the corporate governance reforms.
  4. Corporate governance reforms implemented during litigation include improved risk structure and programs, additional employee training, expanded risk oversight, and changes to Board composition.
  5. Plaintiffs' attorneys' fees and expenses of $33,333,333 are payable in Wells Fargo common stock, with a company cash or stock top-up if the share value falls below $33 million.
  6. The settlement covers claims tied to seven consent orders (2016 CFPB and OCC, 2018 FRB, CFPB, and OCC, 2021 OCC, and 2022 CFPB) and releases the Individual Defendants and related parties, excluding D&O insurance claims.
  7. Defendants deny all wrongdoing; the settlement is not final and requires court approval at the July 24, 2025 Settlement Hearing.

Frequently Asked Questions

  1. Will Wells Fargo shareholders receive a cash payout from this settlement?

    No. The $100 million is paid to Wells Fargo itself, not to shareholders, because this was a derivative action brought on the company's behalf. Shareholders benefit only indirectly through the recovery and the governance reforms.

  2. Who is paying the $100 million settlement amount?

    The payment is funded by Wells Fargo's directors' and officers' excess liability insurers, who committed to pay on behalf of the individual defendants. The filing does not indicate that Wells Fargo corporate capital is used for the monetary consideration, apart from the attorneys' fee arrangement.

  3. Does the settlement admit wrongdoing by Wells Fargo or its executives?

    No. The defendants deny the allegations and any wrongdoing or liability, and the stipulation states it is not an admission. The defendants entered the settlement to avoid the cost, disruption, and uncertainty of further litigation.

  4. What happens next and when is the settlement finalized?

    A Settlement Hearing before Judge Jeffrey S. Ross is scheduled for July 24, 2025. Shareholders who want to object must file notice by July 17, 2025 and submit supporting papers by June 25, 2025. The settlement becomes effective only after court approval, board approval, and the Final Date, after which the $100 million is due within 15 calendar days.

  5. How much will Wells Fargo pay in attorneys' fees, and in what form?

    Wells Fargo agreed to pay $33,333,333 in attorneys' fees and expenses to plaintiffs' counsel, in the form of Wells Fargo common stock valued at the 10-day VWAP before the final judgment. If the value falls below $33 million at payment, the company will contribute the difference in cash or stock. The fee amount is subject to court approval.